Nateglinide for type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2001年 / 43卷 / 1101期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [21] Nateglinide improves glycemic control alone and in combination with troglitazone in Type 2 diabetes
    Gatlin, M
    Rosenstock, J
    Mallows, S
    Bush, C
    DIABETOLOGIA, 2000, 43 : A188 - A188
  • [22] The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
    Guardado-Mendoza, Rodolfo
    Prioletta, Annamaria
    Jimenez-Ceja, Lilia M.
    Sosale, Aravind
    Folli, Franco
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (05) : 936 - 943
  • [23] Nateglinide - current and future role in the treatment of patients with type 2 diabetes mellitus
    Campbell, IW
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (10) : 1218 - 1228
  • [24] Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes
    Lindsay, JR
    McKillop, AM
    Mooney, MH
    O'Harte, FPM
    Flatt, PR
    Bell, PM
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (03) : 167 - 173
  • [25] Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus
    Fonseca, VA
    Kelley, DE
    Cefalu, W
    Baron, MA
    Purkayastha, D
    Nestler, JE
    Hsia, S
    Gerich, JE
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (10): : 1331 - 1335
  • [26] Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes
    Juurinen, L.
    Tiikkainen, M.
    Saltevo, J.
    Nikkila, K.
    Lanki, H.
    Leppavuori, E.
    Kock, T.
    Teikari-Myyra, T.
    Kauppinen-Makelin, R.
    Kotronen, A.
    Yki-Jarvinen, H.
    DIABETIC MEDICINE, 2009, 26 (04) : 409 - 415
  • [27] Effect of nateglinide on nonalcoholic fatty liver disease as a complication in type 2 diabetes
    Matsuura, Kenichi
    Mori, Yutaka
    Itoh, Yohta
    Tajima, Naoko
    DIABETES, 2007, 56 : A555 - A555
  • [28] The effect of nateglinide on postprandial hyperglycemia and oxidative stress in Type 2 diabetes mellitus
    Yoo, Jeong Seon
    Nam, Ji Sun
    Jung, Han Young
    Han, Jung Woo
    Cho, Min Ho
    Park, Jong Suk
    Ahn, Chul Woo
    Cha, Bong Soo
    Kim, Kyung Rae
    Lee, Hyun Chul
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S73 - S73
  • [29] Nateglinide added to metformin offers safe and effective treatment for type 2 diabetes
    Marre, M
    Whatmough, I
    Pongowski, M
    Guitard, C
    DIABETES, 2000, 49 : A361 - A361
  • [30] Is low-dose continuous nateglinide as effective as high-dose three times daily nateglinide in type 2 diabetes?
    de Serna, DG
    Alba, FM
    Schwarz, KE
    Tsewang, DW
    Carroll, MF
    Schade, DS
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S106 - S106
12345